SEB Asset Management’s Oruka Therapeutics ORKA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.4M Hold
196,753
– – 0.06% 248
2026
Q2
$18.7M Buy
+196,753
New +$13.1M 0.07% 232

Other funds holding ORKA

SEB Asset Management's ORKA Position: Q3 2026 in Review

SEB Asset Management held its Oruka Therapeutics (ORKA) position steady in Q3 2026 at 196,753 shares worth $16.4M. The position accounts for 0.06% of the portfolio, ranked #248.

SEB Asset Management first reported a position in ORKA in Q2 2026 and has held it in 2 quarters since. The position peaked at $18.7M in Q2 2026. 232 funds tracked by Wall St. Rank hold ORKA as of Q3 2026.

  • SEB Asset Management held 196,753 shares of Oruka Therapeutics worth $16.4M as of Q3 2026.
  • SEB Asset Management left its Oruka Therapeutics share count unchanged in Q3 2026.
  • Oruka Therapeutics made up 0.06% of SEB Asset Management's portfolio in Q3 2026, its #248 holding.
  • SEB Asset Management first reported a position in Oruka Therapeutics in Q2 2026 and has held it in 2 quarters since.
  • SEB Asset Management's Oruka Therapeutics position peaked at $18.7M in Q2 2026.
  • 232 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.